Exagen
People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Jan. 23, 2023.
Earnings Roundup: Waters, Personalis, Opko Health, Biodesix, Exagen
Waters, Personalis, Opko Health, Biodesix, and Exagen reported quarterly financial results this week.
Exagen, QMUL to Develop Molecular Signatures for Rheumatoid Arthritis Therapy Selection
The assays under development will segment patients according to gene expression in their synovial tissue biopsies to personalize therapy selection.
Industry experts say a receptive market and investor interest in new technologies have spurred the increase in genomics tools and molecular diagnostics IPOs.
Exagen Records Sharp Increase in Revenues for First Nine Months of 2014
NEW YORK (GenomeWeb) – Exagen Diagnostics said in a regulatory document that its revenues through the first nine months of 2014 grew almost four-fold year over year.
Sep 24, 2014
Jul 22, 2014
Exagen Raises $3.95M
Oct 30, 2013
Oct 18, 2013
Exagen Diagnostics Raises $5M
Oct 25, 2012
New York Approves Exagen Lupus Test
Oct 11, 2010
Genomic Tests Firm Exagen Buying Cypress’ Dx Biz
Jul 8, 2010
Exagen Receives CAP Accreditation
Feb 16, 2010
EndoChoice to Promote Exagen Tests
Dec 2, 2009
Pairings: Dec 2, 2009
Premium
Feb 20, 2009
People in the News: Feb 20, 2009
Feb 18, 2009